Abstract
Hyperglycemic crisis episodes (HCEs)—diabetic ketoacidosis and the hyperosmolar hyperglycemic state—are the most serious acute metabolic complications of diabetes. We aimed to investigate the subsequent mortality after HCE in the non-elderly diabetic which is still unclear. This retrospective national population-based cohort study reviewed, in Taiwan’s National Health Insurance Research Database, data from 23,079 non-elder patients (≤65 years) with new-onset diabetes between 2000 and 2002: 7693 patients with HCE and 15,386 patients without HCE (1:2). Both groups were compared, and follow-up prognoses were done until 2011. One thousand eighty-five (14.1 %) patients with HCE and 725 (4.71 %) patients without HCE died (P < 0.0001) during follow-up. Incidence rate ratios (IRR) of mortality were 3.24 times higher in patients with HCE than in patients without HCE (P < 0.0001). Individual analysis of diabetic ketoacidosis and hyperosmolar hyperglycemic state also showed the similar result with combination of both. After stratification by age, mortality was significant higher in the middle age (40–64 years) [IRR 3.29; 95 % confidence interval (CI) 2.98–3.64] and young adult (18–39 years) (IRR 3.91; 95 % CI 3.28–4.66), but not in the pediatric subgroup (<18 years) (IRR 1.28; 95 % CI 0.21–7.64). The mortality risk was highest in the first month (IRR 54.43; 95 % CI 27.98–105.89), and still high after 8 years (IRR 2.05; 95 % CI 1.55–2.71). After adjusting for age, gender, and selected comorbidities, the mortality hazard ratio for patients with HCE was still four times higher than for patients without HCE. Moreover, older age, male gender, stroke, cancer, chronic obstructive pulmonary disease, congestive heart failure, and liver disease were independent mortality predictors. HCE significantly increases the subsequent mortality risk in the non-elderly with diabetes. Strategies for prevention and control of comorbidities are needed as soon as possible.
Similar content being viewed by others
References
A.E. Kitabchi, G.E. Umpierrez, J.M. Miles, J.N. Fisher, Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7), 1335–1343 (2009)
Centers for Disease Control and Prevention, National hospital discharge survey (2014), http://www.cdc.gov/nchs/nhds.htm. Accessed 14 May 2014
National Center for Health Statistics, National hospital discharge and ambulatory surgery data [article online] (2014), http://www.cdc.gov/nchs/ and at: http://www.cdc.gov/nchs/ahcd.htm. Accessed 14 May 2014
S. Kim, Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care 30(5), 1281–1282 (2007)
Agency for Healthcare Research and Quality, Databases and related tools from HCUP: fact sheet [article online], National Center for Health Statistics, Centers for Disease Control (2014), http://www.ahrq.gov/research/findings/factsheets/tools/hcupdata/index.html. Accessed 14 May 2014
H.A. Fishbein, P.J. Palumbo, Acute metabolic complications in diabetes, in National Diabetes Data Group. Diabetes in America, (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 1995), pp. 283–292
S.T. Chung, G.G. Perue, A. Johnson, N. Younger, C.S. Hoo, R.W. Pascoe, M. BoyneS, Predictors of hyperglycaemic crises and their associated mortality in Jamaica. Diabetes Res. Clin. Pract. 73(2), 184–190 (2006)
R.J. MacIsaac, L.Y. Lee, K.J. McNeil, C. Tsalamandris, G. Jerums, Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern. Med. J. 32(8), 379–385 (2002)
C.C. Huang, S.C. Kuo, T.W. Chien, H.J. Lin, H.R. Guo, W.L. Chen, J.H. Chen, S.H. Chang, S.B. Su, Predicting the hyperglycemic crisis death (PHD) score: a new decision rule for emergency and critical care. Am. J. Emerg. Med. 31(5), 830–834 (2013)
J. Wang, D.E. Williams, K.M. Narayan, L.S. Geiss, Declining death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985–2002. Diabetes Care 29(9), 2018–2022 (2006)
C.C. Huang, H.J. Lin, S.C. Chen, S.C. Kuo, W.L. Chen, J.H. Chen, H.Y. Wang, H.R. Guo, Cancer history, bandemia, and serum creatinine are independent mortality predictors in patients with infection-precipitated hyperglycemic crises. BMC Endocr. Disord. 13, 23 (2013)
C.C. Huang, T.W. Chien, S.B. Su, H.R. Guo, W.L. Chen, J.H. Chen, S.H. Chang, H.J. Lin, Y.F. Wang, Infection, absent tachycardia, cancer history, and severe coma are independent mortality predictors in geriatric patients with hyperglycemic crises. Diabetes Care 36(9), e151–e152 (2013)
W. Chou, M.H. Chung, H.Y. Wang, J.H. Chen, W.L. Chen, H.R. Guo, H.J. Lin, S.B. Su, C.C. Huang, C.C. Hsu, Clinical characteristics of hyperglycemic crises in patients without a history of diabetes. J. Diabetes Investig. 5(6), 657–662 (2014)
S.P. Efstathiou, A.G. Tsiakou, D.I. Tsioulos, I.D. Zacharos, A.G. Mitromaras, S.E. Mastorantonakis, T.N. Panagiotou, T.D. Mountokalakis, A mortality prediction model in diabetic ketoacidosis. Clin. Endocrinol. (Oxf) 57(5), 595–601 (2002)
C.C. Huang, S.F. Weng, K.T. Tsai, P.J. Chen, H.J. Lin, J.J. Wang, S.B. Su, W. Chou, H.R. Guo, C.C. Hsu, Long-term mortality risk after hyperglycemic crisis episodes in geriatric patients with diabetes: a national population-based cohort study. Diabetes Care 38(5), 746–751 (2015)
T.M. Cheng, Taiwan’s national health insurance system: high value for the dollar, in Six countries, six reform models: the healthcare reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan, ed. by K.G. Okma, L. Crivelli (World Scientific, Hackensack, 2009), pp. 171–204
R.E. Brown, M.C. Riddell, A.K. Macpherson, K.L. Canning, J.L. Kuk, All-cause and cardiovascular mortality risk in U.S. adults with and without type 2 diabetes: influence of physical activity, pharmacological treatment and glycemic control. J. Diabetes Complicat. 28(3), 311–315 (2014)
J.M. Robbins, G.E. Thatcher, D.A. Webb, V.G. Valmanis, Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study. Diabetes Care 31(4), 655–660 (2008)
M.M. Funnell, T.L. Brown, B.P. Childs, L.B. Haas, G.M. Hosey, B. Jensen, M. Maryniuk, M. Peyrot, J.D. Piette, D. Reader, L.M. Siminerio, K. Weinger, M.A. Weiss, National standards for diabetes self-management education. Diabetes Care 32(S1), S87–S94 (2009)
J.I. Malone, A.W. Root, Plasma free insulin concentrations: keystone to effective management of diabetes mellitus in children. J. Pediatr. 99(6), 862–867 (1981)
H.C. Yeh, E.A. Platz, N.Y. Wang, K. Visvanathan, K.J. Helzlsouer, F.L. Brancati, A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 35(1), 113–118 (2012)
S.F. Ehrlich, C.P. Quesenberry Jr, S.K. Van Den Eeden, J. Shan, A. Ferrara, Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33(1), 55–60 (2010)
C.C. Hsia, P. Raskin, Lung function changes related to diabetes mellitus. Diabetes Technol. Ther. 9(S1), S73–S82 (2007)
A.A. Litonjua, R. Lazarus, D. Sparrow, D. Demolles, S.T. Weiss, Lung function in type 2 diabetes: the normative aging study. Respir. Med. 99(12), 1583–1590 (2005)
T.M. McKeever, P.J. Weston, R. Hubbard, A. Fogarty, Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 161(6), 546–556 (2005)
D.A. Lawlor, S. Ebrahim, G.D. Smith, Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia 47(2), 195–203 (2004)
F. Innocenti, A. Fabbri, R. Anichini et al., Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res. Clin. Pract. 25(3), 161–168 (1994)
D.C. Weir, P.E. Jennings, M.S. Hendy, A.H. Barnett, P.S. Burge, Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 43(9), 725–726 (1998)
G.A. Nichols, T.A. Hillier, J.R. Erbey, J.B. Brown, Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24(9), 1614–1619 (2001)
G.A. Nichols, C.M. Gullion, C.E. Koro, S.A. Ephross, J.B. Brown, The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27(8), 1879–1884 (2004)
R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, M. Muggeo, Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22(5), 756–761 (1999)
B. Balkau, A. Randrianjohany, L. Papoz, E. Eschwège, Re: “A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus”. Am. J. Epidemiol. 134(12), 1469–1470 (1991)
K.G. Tolman, V. Fonseca, A. Dalpiaz, M.H. Tan, Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 30(3), 734–743 (2007)
Acknowledgments
This study was supported by grants CMFHR10384 from the Chi-Mei Medical Center. This study is based in part on data from the Taiwan National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare, and managed by National Health Research Institutes (Registered number NHIRD-100-057, NHIRD-102-024). The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare or National Health Research Institutes. We thank Bill Franke for his invaluable advice and editorial assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
No potential conflicts of interest relevant to this article were reported.
Additional information
Yuan Kao and Chien-Chin Hsu have contributed equally to this work as first authors.
Rights and permissions
About this article
Cite this article
Kao, Y., Hsu, CC., Weng, SF. et al. Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study. Endocrine 51, 72–82 (2016). https://doi.org/10.1007/s12020-015-0669-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0669-8